Bigul

Updates

Please find enclosed Investor Presentation of our company
13-05-2017
Bigul

Schedule Of Conference Call For Investors

With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Monday, May 15, 2017 at 3:00 p.m. IST to discuss the Audited Financial Results for the Q4 & Financial Year ended 31st March, 2017, to be declared on 13th May, 2017.
11-05-2017
Bigul

Closure of Trading Window

With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Board Meeting of our Company will be held on Saturday, the 13th May, 2017 at 10.30 a.m. at the Registered Office, SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad 500034 of the Company, to consider, inter alia, and take on record the following matters: To consider and approve...
03-05-2017
Bigul

Submission Of Compliance Certificate Under Regulation 40(10) For The Half-Year Ended 31St March, 2017

With reference to above subject, please find enclosed Compliance Certificate for the half-year ended 31st March, 2017 issued by the Practicing Company Secretary, under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015.
17-04-2017
Bigul

Statement Of Investor Complaints/Grievances,For The Quarter Ended 31St March, 2017

Pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the statement of Investor complaints/grievances, for the quarter ended 31st March, 2017.
13-04-2017
Bigul

Shareholding for the Period Ended March 31, 2017

Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here
12-04-2017
Bigul

Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended 31St March, 2017

With reference to the above subject, please find enclosed compliance certificate for the half-year ended 31st March, 2017 duly signed by the Compliance Officer and authorised representative of the share transfer agent (Karvy Computershare Pvt.Ltd., Hyderabad), under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
11-04-2017
Bigul

Company news

Suven Life Sciences on Tuesday said it has secured a product patent in New Zealand for treatment of disorders associated with neurodegenerative diseases. The patent is valid up to 2033, the company...
28-03-2017
Next Page
Close

Let's Open Free Demat Account